Silicone oils induce corneal and retinal pathologic changes by undefined mechanisms that may relate to certain components. Low-molecular-weight components have often been postulated to cause these ocular toxicities. Several types of additives that occur as contaminants or by-products in crude silicone oils were tested for their effects on rabbit corneal endothelial permeability. A purified oil plus various additives was perfused to fill about 75% of anesthetized rabbit anterior chambers. In vitro endothelial permeabilities to inulin and dextran were determined after 1 week. A long-chain silanol-terminated polydimethylsiloxane (viscosity, 1000 cps) at 2 mg/ml, a catalyst (tetramethylammonium siloxanolate) at 1 mg/ml, and a mixture of a series of linear compounds (hexamethyldisiloxane [MM] through hexacosamethyldodecasiloxane [MD 10M]) each at 10 mg/ml, resulting in the largest permeability increase. A mixture of two short-chain silanol-terminated compounds (15–35 cps plus 80 cps, each at 1 mg/ml) was less damaging, while the cyclic series gave ambiguous results. One series of hexamethylcyclotrisiloxane (D3), octamethylcyclotetrasiloxane (D4), and decamethylcyclopentasiloxane (D5) produced a modest increase in permeability, while another identical series from a different supplier had no effect and a mixture of a long series of various cyclic compounds from D3–D21 was without effect. Certain compounds have greater potential to induce toxic effects on the corneal endothelium including a linear series, a silanol-terminated polydimethylsiloxane, and a catalyst. Toxicity could reside in relatively few compounds; of these the linear series and the catalyst have been identified in silicone oils.
No takes yet. Share an insight, caveat, or question.
Green et al. (1993) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: